Transforming therapeutics through precision exosome-based drug delivery

KaRMa Exotechnologies was founded by scientists with decades of expertise in reproductive pharmacology, extracellular vesicle biology, and translational medicine.
Our team bridges basic science, engineering, and clinical research to bring novel therapeutics from bench to bedside.
Backed by multiple NIH-funded grants and supported by a GMP-compliant manufacturing pipeline, we are uniquely positioned to accelerate the development and testing of exosome-based therapeutics.
At KaRMa ExoTechnology, we unlock the power of extracellular vesicles (EVs)—nature’s own messengers—to transform how drugs are delivered to cells, tissues, and organs.
We are actively developing and partnering on exosome-enabled therapies for:
We collaborate with research institutions and pharmaceutical partners to:
Looking to advance your therapeutic strategy with exosomes?
KaRMa offers:
Interested in partnering, investing, or working with us?
Reach out — we’d love to hear from you.
We love our customers, so feel free to visit during normal business hours.
Kammala@karmaexotechnologies.com Samantha@karmaexotechnolgies.com
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |